ARCHIVES

Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

First Chop Awards Made, 17 Others In Negotiation For NCI Program To Upgrade Community Cancer Care

October 24, 1980

Competing Core, P01 Grants Held To 7% Increases To Help Spread $$ Around

December 7, 1979

Funding opportunities listed.

June 18, 2004

Congressional Appropriations Committee Leaders Blast White Plans To Slash NIH FY 1987 Budget

February 20, 1987

One Flexible Sigmoidoscopy Can Reduce Risk by 31 Percent

September 30, 2011

Duke Insiders Allege Intimidation By Administration

July 23, 2010